Operator of a medicinal technology platform intended to develop drugs through gene engineering mAb research technology. The company's medicinal technology platform is mainly engaged in genetically engineered antibody drug research and development, enabling medical institutions and patients suffering from deadly diseases with a chance to get a cure from diseases such as Ebola and chronic lymphocytic leukaemia.